Wachtell and Skadden lead Pfizer/Array deal
Pfizer has announced that it will purchase Colorado-based Array Pharmaceuticals in an $11 billion acquisition that adds to Pfizer’s cancer treatment portfolio.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10